Staffan Strömberg

Company: Infant Bacterial Therapeutics AB

Job title: Chief Executive Officer

Seminars:

Paving the Regulatory Footpath: Current Perspectives & Future Considerations 12:15 pm

Working around integrating technical development within a regulated environment across CMC, preclinical to clinical stage Establishing regulatory strategies in an environment where there’s a lack of frameworks and guidelines Revealing future visions for microbiome regulations and preparing for long term initiativesRead more

day: Day 1 Track A AM

Panel Discussion: Hearing Investment Perspectives to Navigate the Current Investment Climate & Take Part in a Reverse Pitch Opportunity 9:30 am

Uncovering the hottest areas of investment in the microbiome world to understand which features of a business attract funds Exploring how you can transform your development plans to attract more investment Partake in a reverse pitch sessions, giving you the chance to ask these investment experts your burning questionsRead more

day: Conf Day 1

A Development Journey: Navigating the Challenges & Opportunities in Medical Interventions 8:30 am

Applying medications to life-threatening disease in premature infants including NEC and sepsis Considering product quality for a highly vulnerable patient population with the ambition for IBP-9414 to become the world’s first approved medication for premature infants Examining the data from the largest randomized controlled trial in the premature infants everRead more

day: Conf Day 1